Jordan Lane

Dr. Jordan Lane has extensive experience in the AI drug discovery space and is driven by a profound commitment to revolutionizing drug discovery, integrating artificial intelligence with bioscience to enhance drug safety and efficacy. At Ignota Labs, Dr. Lane leads innovation, leveraging his extensive background in biochemistry, genetics, and AI to pioneer transformative treatments in global patient care. His journey began at the University of Nottingham, where he earned a BSc in Biochemistry and Genetics, followed directly by a PhD focused on Alzheimer's Disease. His work led to strategic roles in the biopharmaceutical industry, from developing oncology assets at AstraZeneca to spearheading AI-driven drug discovery projects at LabGenius and BenevolentAI. At Ignota Labs Dr Lane leads a relentless pursuit of excellence, interdisciplinary collaboration, and a visionary approach to the future of medicine.